New and Under-utilized Vaccines Implementation (NUVI)

Decision making and Implementation of Pneumococcus Vaccines

Surveillance

VP-IBD Surveillance: Tier 2 Meningitis-Sepsis-Pneumonia Surveillance

Percent of probable meningitis with HI, Spn or NM identified, by country and WHO region, 2009

IBD Surveillance - Countries participating in the WHO Network and Reporting Data for 2009

Countries in WHO VP-IBD Surveillance Network, by WHO Region and GAVI Eligibility, 2009

Tier 1 VP-IBD Countries: Meningitis Surveillance

Tier 1: Meningitis Surveillance Data, 2008 Compared with 2009

Percent of suspected meningitis cases with probable bacterial meningitis, by country and WHO Regions, 2009

Percent of Probable Bacterial Meningitis Cases with HI, by Years of Hib Vaccine Introduction & WHO Region, 2009 (regional medians with country-specific ranges)

IBD Surveillance, Tier 2 Meningitis-Sepsis-Pneumonia Numbers of reporting countries & children enrolled with pneumonia with % change from 2008 to 2009, by WHO region

Tier 2: Meningitis-Pneumonia-Sepsis Detected Organisms, 2009

Spn. Serotype Data, Tier 1: Meningitis

IBD and Rotavirus Global and Regional Laboratory Network Structure, 2010

Last updated : February 2011

Share
Email Twitter Facebook Google Delicious LinkedIn
More...

Table of contents

  1. Disease burden
  2. Vaccine Utilization
  3. Surveillance